Curis Inc

Curis Inc (CRIS) Financials

$1.490

-0.010 (-0.67%)At close

CRIS Comparative Benchmarking

In the context of the broader market, CRIS competes directly with industry leaders such as BCAB and CHGA. With a market capitalization of $4.37M, it holds a leading position in the sector. When comparing efficiency, CRIS's gross margin of N/A stands against BCAB's 100.00% and CHGA's N/A. Such benchmarking helps identify whether Curis Inc is trading at a premium or discount relative to its financial performance.

Curis Inc Financial Performance

Curis reported total revenue of $2.93 million in Q3 2024, but faced a net loss of $24.2 million in Q1 2026, reflecting ongoing financial challenges. Despite this, the gross margin was exceptionally high at 104.37% in Q3 2024, indicating strong product profitability when operational issues are resolved.

Financials

FY2026Q2
YoY:
-100.00%
0.00
Total Revenue
FY2026Q2
YoY:
+14.45%
-9.94M
Operating Profit
FY2026Q2
YoY:
-0.14%
-8.58M
Net Income after Tax
FY2026Q2
YoY:
-70.46%
-4.02
EPS - Diluted
FY2025Q4
YoY:
-31.20%
-6.37M
Free Cash Flow
FY2025Q4
YoY:
-2.21%
72.41
Gross Profit Margin - %
FY2025Q4
YoY:
-20.58%
-288.05
FCF Margin - %
FY2025Q4
YoY:
-691.55%
1.70K
Net Margin - %

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started